Cefotaxime Induced Staphylococcal Scalded Skin Syndrome: A Case Report | Zendy

S. Vivek Jakkula | Zendy; Satish Chinnala | Zendy; Shravani Komuravelly | Zendy; Venkateshwarlu Eggadi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cefotaxime Induced Staphylococcal Scalded Skin Syndrome: A Case Report

Author(s) -

S. Vivek Jakkula,

Satish Chinnala,

Shravani Komuravelly,

Venkateshwarlu Eggadi

Publication year - 2021

Publication title -

indian journal of pharmacy practice

Language(s) - English

Resource type - Journals

ISSN - 0974-8326

DOI - 10.5530/ijopp.14.2.29

Subject(s) - staphylococcal scalded skin syndrome , cefotaxime , medicine , dermatology , toxic epidermal necrolysis , immunity , staphylococcus aureus , immunology , antibiotics , microbiology and biotechnology , immune system , biology , bacteria , genetics

Staphylococcal Scalded Skin Syndrome (SSSS) is as well called as Ritter von Ritterschein disease, Lyell disease, Ritter disease and staphylococcal necrolysis of the epidermis. More common in neonates and children of age less than five years and are at a greater risk of SSSS. To fight against SSSS, children should attain lifetime immunity in the form of antibodies against exotoxins of staphylococcal strains. Symptoms include fever and redness on the overall surface of skin. Within 24-48h, fluid-filled blisters appear on the body. We report a case of 2-year-old male child developed SSSS after intravenous administration of Cefotaxime.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research